drugset / Trial / NCT00771524

Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone

NCT00771524

Phase 1 Completed 22 enrolled Basilea Pharmaceutica
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

This study is being performed to measure the amount of the antibiotic ceftobiprole (study drug) found in the bone and blood after receiving one dose prior to your elective hip replacement surgery. A piece of your hip bone which will be removed as part of your surgery will be analyzed to determine how much ceftobiprole gets into the bone.

Timeline

Start
2009-04
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftobiprole Small molecule 500 mg Intravenous

Indications

No indication recorded.